Premium
Gain Therapeutics Inc (GANX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applicatio... Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.855 | 51.9756838906 | 1.645 | 2.6496 | 1.55 | 540554 | 2.11394847 | CS |
| 4 | 0.7741 | 44.8519612956 | 1.7259 | 2.6496 | 1.5 | 243300 | 1.87584167 | CS |
| 12 | 0.558 | 28.7332646756 | 1.942 | 3.19 | 1.5 | 300309 | 2.15501133 | CS |
| 26 | 1.31 | 110.084033613 | 1.19 | 3.19 | 0.89 | 320789 | 1.67303585 | CS |
| 52 | -1.23 | -32.9758713137 | 3.73 | 5.33 | 0.89 | 261854 | 2.13680595 | CS |
| 156 | -2.95 | -54.128440367 | 5.45 | 6.7 | 0.89 | 132190 | 2.69604693 | CS |
| 260 | -8.72 | -77.7183600713 | 11.22 | 17.93 | 0.89 | 124764 | 3.84518999 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
